LLY vs NVO: Which Stock is Better?
Side-by-side comparison of Eli Lilly & Co and Novo Nordisk A S in 2026
LLY
Eli Lilly & Co
$1051.99
NVO
Novo Nordisk A S
$37.45
Key Metrics Comparison
| Metric | LLY | NVO | Winner |
|---|---|---|---|
| Market Cap | $992.40B | $167.22B | LLY |
| P/E Ratio | 45.88 | 10.34 | NVO |
| EPS (TTM) | $22.93 | $3.64 | LLY |
| Revenue Growth | 0.4% | -0.1% | LLY |
| Gross Margin | 83.0% | 82.4% | LLY |
Analyze LLY
Full quant analysis
Analyze NVO
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LLY or NVO a better investment?
Comparing LLY and NVO: Eli Lilly & Co has a market cap of $992.40B while Novo Nordisk A S has $167.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LLY and NVO?
LLY (Eli Lilly & Co) and NVO (Novo Nordisk A S) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LLY or NVO?
Based on P/E ratios, NVO trades at a lower multiple (10.3x vs 45.9x).
Which is growing faster: LLY or NVO?
LLY has higher revenue growth at 0.4% vs -0.1% for NVO.
Which company is more profitable: LLY or NVO?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 82.4% for NVO.
Which is the larger company: LLY or NVO?
Eli Lilly & Co (LLY) is larger with a market cap of $992.40B compared to $167.22B for NVO.
Should I buy LLY or NVO in 2026?
Both LLY and NVO have investment merit. LLY trades at $1051.99 while NVO trades at $37.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LLY and NVO stock?
Key differences: Market Cap ($992.40B vs $167.22B), P/E Ratio (45.9x vs 10.3x), Revenue Growth (0.4% vs -0.1%), Gross Margin (83.0% vs 82.4%).